Navigation Links
Nerites Technology Wins Scientific Accolades
Date:6/23/2008

MADISON, Wis., June 23 /PRNewswire/ -- Anti-fouling medical device coatings developed by Nerites Corporation have received several recent awards recognizing innovation in medical technology. Collaborators at the University of Western Ontario and the Lawson Health Research Institute tested urinary stents coated with Nerites' polymers, and demonstrated a significant reduction in animal infection levels.

Unlike active antibiotic-releasing coatings, which cannot protect against resistant bacterial strains, the Nerites technology passively prevents bacteria from attaching to the medical device and forming an infectious biofilm. In this way, the passive coating may have both greater efficacy and fewer side effects than active coatings. Recognition for this work includes:

-- First place in the New Investigator Competition at the 2008 Society for Infection and Inflammation in Urology Annual Meeting

-- Top Research Poster at the 61st Annual Meeting of The Urological Society of Australia and New Zealand

-- First place in the Basic Science Division at the 2007 Endourological Society Fellowship Essay Competition

-- Publication in the Journal of Endourology in June, 2008

The research was led by Peter Cadieux and Hassan Razvi, of the University of Western Ontario, and Raymond Ko, of the University of Sydney. "Urinary conditioning films that form on medical devices are notorious for covering up the effects of existing coatings, augmenting bacterial attachment and providing nutrients to the microbes," stated Cadieux. "By preventing the attachment of both bacteria and urine, the Nerites' coatings demonstrate great promise for preventing biofilm formation and related infections."

"We're really pleased to have our coatings technology validated by our academic partners and their peers in medical research," stated CEO Tom Mozer, "we hope that corporate partners will also be interested in bringing this innovation to the millions of patients who may suffer from device-related infections."

About Nerites: Nerites Corporation develops fully-synthetic, water-resistant adhesives, sealants, and coatings for internal medical use. The hydrogel technology can be used to close internal tears or incisions, to seal tissues and prevent leakage and infection, and to affix synthetic or biologic medical devices. Properties can be "tuned" to fit each application. The technology was described with a cover article in the journal Nature (July, 2007) and was labeled "one of the top 100 scientific developments of 2007" by Discover Magazine. (http://www.Nerites.com)


'/>"/>
SOURCE Nerites Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Nerites Corporation Announces Closing of Series A Funding Round
2. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
3. ONR offers up to $1M for innovative science and technology ideas
4. Revolutionary Therapy: Needle-Free Technology for the Treatment Of Blinding Eye Disease
5. Plexus Online Enables Business-Government-Academic Collaboration for Advanced Technology Institute
6. China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute
7. Shanghai Medical Technology Co., First Quarter 2008 Financial Results
8. Micromagnets May One Day Enhance MRI Technology
9. SAND Technology Appoints Zainab Ahmed Schwartz as CFO
10. Pop! Technology Goes Growthink
11. Medicsight ColonCAD Technology Successfully Identified Cancer in 100% of Patients Included in Data Presented at ESGAR 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology: